These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9951492

  • 1. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
    Larkin G, Lightman S.
    Ophthalmology; 1999 Feb; 106(2):370-4. PubMed ID: 9951492
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 5. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR.
    Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Apr; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 10. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M.
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
    Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS.
    Ophthalmology; 2003 May; 110(5):1061-5. PubMed ID: 12750115
    [Abstract] [Full Text] [Related]

  • 13. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE.
    Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
    Takebe N, Cheng X, Wu S, Bauer K, Goloubeva OG, Fenton RG, Heyman M, Rapoport AP, Badros A, Shaughnessy J, Ross D, Meisenberg B, Tricot G.
    Clin Cancer Res; 2004 Dec 15; 10(24):8301-8. PubMed ID: 15623606
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 16. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI, Quiroga J, Sangro B, Girala M, Gómez-Manero N, Pardo F, Alvárez-Cienfuegos J, Prieto J.
    Liver Transpl Surg; 1999 Sep 15; 5(5):414-20. PubMed ID: 10477843
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
    Choudhary A, Harding SP, Bucknall RC, Pearce IA.
    J Ocul Pharmacol Ther; 2006 Jun 15; 22(3):168-75. PubMed ID: 16808677
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
    Kolomeyer AM, Ragam A, Shah K, Jachens AW, Tu Y, Chu DS.
    Ocul Immunol Inflamm; 2012 Apr 15; 20(2):113-8. PubMed ID: 22409564
    [Abstract] [Full Text] [Related]

  • 19. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G, Griesmacher A, Zuckermann AO, Laufer G, Mueller MM.
    Clin Pharmacol Ther; 2001 Mar 15; 69(3):137-44. PubMed ID: 11240978
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y, Ohgane T.
    Nihon Yakurigaku Zasshi; 2001 Feb 15; 117(2):131-7. PubMed ID: 11233304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.